Month: September 2022

Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. Hansen INDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced data will be released at ESMO Congress 2022 in Paris, France about the efficacy and safety of PNT2002 in the lead-in cohort of the SPLASH trial. An abstract is now available on the ESMO congress website at https://cslide.ctimeetingtech.com/esmo2022/attendee/confcal_2/presentation/list?q=1400P, and an e-poster which contains updated data will be published and presented on Sunday, September 11th. The poster is titled “Efficacy and Safety of 177Lu-PNT2002 Prostate-Specific Membrane Antigen (PSMA) Therapy in Metastatic...

Selected recommended phase 2 dose (RP2D) of 480 mg with ongoing enrollment in disease-specific cohorts; maximum tolerated dose (MTD) not reached Stable disease was observed in 10 of 27 evaluable patients in an unselected patient population Comprehensive pharmacodynamic studies indicate the activation of the innate as well as the adaptive immune system Well managed safety profileHEIDELBERG, Germany, Sept. 04, 2022 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that an abstract with clinical trial results of its innate cell engager (ICE®) AFM24 has been accepted for a poster presentation at the Congress of the European Society for Medical Oncology (ESMO) from 9-13 September 2022 in Paris. The abstract...

New prevalence figure 22–126% higher than previous estimates Prevalence expected to reach 592 million by 2050 Researchers urge global action on smoking cessation and air pollution reductionBARCELONA, Spain, Sept. 04, 2022 (GLOBE NEWSWIRE) — Over 480 million people worldwide likely suffer from chronic obstructive pulmonary disease, or COPD, according to a late-breaking abstract led by ResMed (NYSE: RMD, ASX: RMD) presented at the European Respiratory Society Congress today.1 This figure is 22–126% higher than today’s most cited estimates, which range from 212–392 million reported over the past decade.2,3,4 COPD is a chronic, progressive disease that restricts a person’s ability to breathe. Early-stage sufferers may use inhaled medications to reduce symptoms. Advanced stages may require supplemental oxygen or mechanical ventilation...

VANCOUVER, British Columbia, Sept. 02, 2022 (GLOBE NEWSWIRE) — BC Moly Ltd. (“BC Moly” or the “Company”) (NEX: BM.H) is pleased to announce today that certain holders of subscription receipts of the Company have exchanged (the “Partial Exchange”) an aggregate of 3,028,788 subscription receipts (the “Partial Exchange Receipts”), purchased for $0.165 per Partial Exchange Receipt (the “Issue Price”), in advance of the satisfaction by the Company of certain escrow release conditions (the “Escrow Release Conditions”). The Partial Exchange resulted in the release from escrow of an aggregate of $499,750 (plus interest, if any, earned thereon) to the Company. The Partial Exchange Receipts constitute a portion of the subscription receipts issued and sold under the non-brokered private placement of subscription receipts of the Company that...

Overall changes in electric and natural gas prices would be effective November 1, 2022 SPOKANE, Wash., Sept. 02, 2022 (GLOBE NEWSWIRE) — Avista (NYSE: AVA) has made annual rate adjustment filings with the utility commissions in Washington and Idaho that, if approved, will result in an increase in electric and natural gas rates in Washington and natural gas rates in Idaho, effective November 1, 2022 Washington Electric Adjustment FilingsTwo electric adjustments were filed, that if approved, are designed to change overall electric revenues as follows:Wildfire Expense Balancing: increase of approximately $5.1 million or 0.9% Residential Exchange Program: decrease of approximately $0.2 million or 0.1%Washington Natural Gas Adjustment FilingThe natural gas adjustment request is the annual natural gas Purchased Gas Cost Adjustment....

HOUSTON, Sept. 02, 2022 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2022. As of August 31, 2022, the Company’s net assets were $1.4 billion, and its net asset value per share was $10.63. As of August 31, 2022, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 516% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 398%. Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesAugust 31, 2022(Unaudited)    (in...

HOUSTON, Sept. 02, 2022 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2022. As of August 31, 2022, the Fund’s net assets were $479.1 million and its net asset value per share was $10.15. As of August 31, 2022, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 500% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 379%.     Kayne Anderson NextGen Energy & Infrastructure, Inc.Statement of Assets and LiabilitiesAugust 31, 2022(Unaudited)    (in...

Company Expected to Continue “Normal Course” Operations SALT LAKE CITY, Sept. 02, 2022 (GLOBE NEWSWIRE) — NewAge, Inc. (Nasdaq: NBEV) (the “Company”) today announced that the U.S. Bankruptcy Court for the District of Delaware has granted the Company interim approval for first day motions related to its Chapter 11 restructuring. The approved motions will support the Company’s ongoing operations during its financial restructuring process. The Court granted the Company access to a debtor-in-possession (“DIP”) financing facility of $16 million provided by DIP Financing, LLC, which combined with the Company’s projected revenues, will support its operations during the Chapter 11 process. The Court has also authorized the Company to continue paying employee wages and benefits, as well as certain operational requirements that allow the...

Leuven, BELGIUM, Boston, MA, US – September 2, 2022 – CET 10:30PM – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that it has amended its mandatory convertible bonds issuance and subscription agreement announced on April 6, 2021 (“funding program”) with the Negma Group, a financial institution focused on supporting growth and capturing value through a multi-strategy approach. The proceeds will be devoted to Oxurion’s KALAHARI Phase 2, Part B clinical trial. The trial is currently underway and is evaluating THR-149, its novel therapeutic for second line therapy, against market leader aflibercept in the treatment of diabetic macular edema (DME) for the 40-50% of DME patients that get...

TULSA, Okla., Sept. 02, 2022 (GLOBE NEWSWIRE) — BOK Financial® will eliminate all non-sufficient funds fees and reduce overdraft fees by the end of 2022. These fees are incurred when there isn’t enough money in an individual’s checking or savings account to cover a transaction whether the transaction was processed (overdraft fees) or rejected (non-sufficient funds fees). By the end of the year, the bank—operating as BOK Financial®, Bank of Oklahoma, Bank of Texas and Bank of Albuquerque—will make the following changes:Eliminate fees charged when checks or payments cannot be processed due to lack of funds, commonly known as non-sufficient funds fees. Reduce the maximum number of overdraft fees charged per day from five to three. Increase the overdraft cushion to $50 from $5, ensuring that customers do not pay overdraft fees when...